NCT01782313View on ClinicalTrials.gov

A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 6, 2013

Primary Completion Date

May 27, 2015

Study Completion Date

December 28, 2016

Conditions
Recurrent Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma
Interventions
DRUG

tivozanib

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (5)

52246

University of Iowa, Iowa City

53792

University of Wisconsin, Madison

55905

Mayo Clinic, Rochester

60611

Northwestern University, Chicago

63110

Washington University, St Louis

Sponsors
All Listed Sponsors
collaborator

AVEO Pharmaceuticals, Inc.

INDUSTRY

lead

Northwestern University

OTHER